Executive Summary
The EPA's landmark 2024 chrysotile asbestos ban stopped new asbestos from entering commerce — but it left untouched the millions of tons of legacy asbestos already installed in buildings, schools, and infrastructure across the United States. Federal law required the EPA to publish a risk management rule for legacy asbestos within one year of completing its risk evaluation. That deadline passed in late 2025 without action. In February 2026, the Asbestos Disease Awareness Organization (ADAO) filed a 60-day notice of intent to sue the EPA under TSCA Section 20(a)(2) — the citizen enforcement provision. This gap means workers renovating pre-1980 structures, residents of older apartment buildings, and occupants of government facilities remain without federal protections specifically addressing legacy asbestos. Here is what attorneys, building owners, and mesothelioma patients need to know.
Effective date of EPA Part 1 chrysotile ban on new asbestos use
Statutory TSCA deadline for EPA to finalize legacy asbestos risk management rule
ADAO files 60-day notice of intent to sue EPA for missing the deadline
Homes and buildings estimated to contain legacy asbestos insulation products
What Is Legacy Asbestos and Why Does It Still Pose a Threat?
Legacy asbestos refers to asbestos-containing materials already installed in buildings and infrastructure before asbestos was phased out of most commercial uses. Insulation, floor tiles, pipe wrapping, ceiling tiles, joint compound, roofing shingles, and dozens of other construction materials installed before 1980 routinely contained asbestos. These materials remain in place in millions of American homes, schools, government buildings, commercial structures, and naval vessels.
Unlike new asbestos imports — which the 2024 Part 1 EPA rule now prohibits — legacy asbestos poses no danger when it remains intact and undisturbed. The hazard emerges during renovation, demolition, maintenance, or deterioration. When asbestos-containing materials are cut, sanded, drilled, or damaged, they release microscopic fibers that can remain airborne for hours. Inhaling those fibers — even in a single high-exposure event — can initiate mesothelioma development with a latency period of 20 to 50 years.
"Legacy asbestos is the litigation landscape I work in every day. The chrysotile ban is meaningful progress, but the majority of mesothelioma cases we see now involve people who were exposed 30 or 40 years ago to materials still sitting in buildings. Until EPA addresses what's already there, those exposures will keep happening — and the cases will keep coming."
There is no federal law requiring building owners to inspect for or remove legacy asbestos outside of the K-12 school context. The Asbestos Hazard Emergency Response Act (AHERA) mandates triennial inspections and asbestos management plans for public and private non-profit K-12 schools — but no equivalent statute governs commercial buildings, apartment complexes, government facilities, or private homes. Workers who encounter asbestos during renovation or demolition are protected by OSHA standards, but those standards are triggered by the work activity, not by proactive building assessment.
What Did EPA's Part 2 Risk Evaluation Find About Legacy Asbestos?
Under the Toxic Substances Control Act (TSCA) as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act of 2016, the EPA must evaluate the risk of chemicals in commerce and those with legacy uses or associated waste. For asbestos, the EPA conducted a two-part evaluation:
- Part 1 — Ongoing commercial uses of chrysotile asbestos — this produced the March 2024 final rule banning chlor-alkali diaphragms, aftermarket automotive brakes, oilfield brake blocks, and gaskets, with phase-out periods through 2036
- Part 2 — Legacy uses of all six asbestos fiber types (chrysotile, amosite, crocidolite, tremolite, anthophyllite, actinolite), legacy disposal of asbestos-containing materials, and associated risks in buildings and the environment
The EPA completed its Part 2 risk evaluation in late 2024, finding unreasonable risks associated with legacy asbestos exposure in occupational settings — particularly during building renovation, maintenance work, and demolition activities. TSCA Section 6(c)(1)(A) requires the EPA to publish a final risk management rule addressing those unreasonable risks within one year of completing the evaluation. That statutory deadline passed without a final rule.
What Is ADAO's Lawsuit and What Could It Force the EPA to Do?
The Asbestos Disease Awareness Organization (ADAO) has been the most active non-governmental litigant in U.S. asbestos regulation. In the Part 1 chrysotile litigation, ADAO filed its own challenge arguing the EPA's rule was too weak — that compliance deadlines extending to 2036 for chlor-alkali facilities violated TSCA Section 6(d)'s requirement that prohibitions take effect "as soon as practicable."
The February 2026 notice represents a different legal theory. TSCA Section 20(a)(2) provides that any person may commence a civil action against the EPA administrator for failing to perform any non-discretionary act or duty. The obligation to publish a risk management rule within the statutory timeframe following completion of a risk evaluation is non-discretionary — the law says "shall," not "may." ADAO's 60-day notice is the procedural prerequisite to filing that citizen suit. If the EPA does not act during the 60-day window, ADAO may proceed to federal court seeking an order compelling publication of the rule.
"What ADAO is doing here is using TSCA's enforcement mechanism exactly as Congress designed it. When EPA doesn't meet its mandatory timelines, the statute gives citizens standing to force action. The theory is straightforward: EPA completed its Part 2 evaluation, found unreasonable risk, and then missed the deadline to manage that risk. A court can order a date certain for a final rule."
If a court orders the EPA to finalize a Part 2 legacy asbestos rule, the regulatory outcome could include mandatory inspection requirements for certain categories of older buildings, enhanced worker protections during renovation and demolition beyond existing OSHA standards, abatement trigger thresholds, and hazard communication requirements for building owners. The scope would ultimately depend on what the EPA found during the Part 2 risk evaluation and how it chose to address those findings.
How Does the Fifth Circuit Chrysotile Ban Litigation Affect This?
The Fifth Circuit is separately reviewing consolidated challenges to the Part 1 chrysotile ban (Case No. 24-60193). In January 2026, the U.S. Chamber of Commerce filed a brief urging the court to vacate the rule, arguing the EPA exceeded its authority by banning chrysotile outright rather than relying on less restrictive workplace safety measures. The court's eventual ruling on the scope of EPA's TSCA authority could significantly shape what a Part 2 legacy asbestos rule would be permitted to contain.
A ruling that narrowly limits EPA's authority to ban rather than regulate through workplace exposure limits would likely constrain the agency's options for addressing legacy asbestos as well. Conversely, a ruling that upholds the Part 1 ban's scope would signal that EPA has broad authority to impose mandatory requirements on legacy asbestos in buildings.
As of March 2026, the chrysotile ban remains in full effect and enforceable. The Trump administration reversed its June 2025 plan to reconsider the ban after significant public pressure — in July 2025, the EPA confirmed it would uphold the Biden-era prohibition. The Fifth Circuit has not yet issued a ruling on the consolidated challenges. The ADAO case provides context on the long history of EPA asbestos regulation, which has consistently involved industry challenges to every significant rulemaking since the agency's 1989 near-total ban was struck down by the Fifth Circuit in 1991.
What Legal Rights Do Mesothelioma Patients Have From Legacy Asbestos Exposure?
The absence of federal legacy asbestos building regulations does not mean victims lack recourse. Mesothelioma patients exposed to legacy asbestos in buildings have multiple independent legal pathways:
Product Liability Against Manufacturers
The manufacturers who originally produced and sold asbestos-containing building materials bear strict liability for the harm caused by their products. Even if the company has since gone bankrupt, their asbestos liability was typically transferred into Section 524(g) bankruptcy trusts. With over 60 trusts currently active and more than $30 billion in combined reserves, asbestos trust fund claims are often the most direct compensation pathway for legacy building exposure.
Premises Liability Against Property Owners
Building owners who knew or should have known about asbestos hazards — and who failed to disclose them to occupants or workers, or who conducted improper renovations that released fibers — may face premises liability claims. The legal theory requires showing that the owner had a duty to maintain safe premises, breached that duty, and that the breach caused the mesothelioma. Prior knowledge of asbestos presence (through prior inspections, building permits showing asbestos-containing materials, or AHERA records for schools) is highly probative evidence.
Workers' Compensation and Occupational Exposure Claims
Workers who developed mesothelioma from occupational exposure during renovation or demolition of asbestos-containing buildings may pursue workers' compensation alongside civil litigation against responsible manufacturers. OSHA violations — failure to provide proper protective equipment, failure to conduct required air sampling, failure to notify workers of asbestos hazards — can support premises liability claims and regulatory complaints.
"The regulatory gap is real, but it doesn't leave victims without options. Every case of legacy building exposure I've handled has a product that can be traced to a manufacturer, a trust fund, or both. The building's age and construction materials are the starting point — we work backward from there to identify every entity that contributed to the exposure."
For patients who may have been exposed to asbestos in buildings, our mesothelioma lawyers directory connects you with attorneys who specialize in legacy building exposure cases. Our free case assessment tool can help identify which compensation pathways apply to your exposure history. You can also call us directly at (866) 222-9990.
Key Facts About Legacy Asbestos and EPA Regulation in 2026
- The 2024 EPA chrysotile ban covers new commercial uses only — it does not require removal of asbestos already in buildings
- TSCA requires EPA to publish a risk management rule within 1 year of completing a risk evaluation — this deadline passed for legacy asbestos in late 2025
- ADAO filed a 60-day notice of intent to sue EPA in February 2026 under TSCA Section 20(a)(2) for failing to act
- No federal law requires building owners to inspect for or remove legacy asbestos outside of K-12 schools (AHERA)
- OSHA's asbestos standard (29 CFR 1910.1001) protects workers during renovation and demolition but does not require proactive inspections
- The Fifth Circuit is reviewing consolidated challenges to the Part 1 chrysotile ban — a ruling limiting EPA authority could constrain the legacy asbestos rule
- As of March 2026, the chrysotile ban remains in full effect; the Trump administration reversed its plan to rewrite the rule in July 2025
- Mesothelioma patients from legacy building exposure can pursue product liability (trust funds), premises liability, and asbestos trust fund claims independently of EPA regulatory status
- Over 60 active asbestos bankruptcy trusts hold $30+ billion in combined reserves for mesothelioma victims
- The WikiMesothelioma Quick Facts page tracks current mesothelioma statistics and compensation benchmarks for patients and families
Frequently Asked Questions
What is legacy asbestos and why isn't it covered by the 2024 EPA chrysotile ban?
Legacy asbestos refers to asbestos-containing materials already installed in buildings, infrastructure, insulation, and equipment before the material was phased out of new construction. The EPA's 2024 Part 1 chrysotile ban stops new asbestos from entering the supply chain but does not require removal of asbestos already in place in schools, workplaces, apartment buildings, government facilities, and other structures. That regulatory gap is addressed under TSCA Part 2, which completed its risk evaluation in late 2024 but has not yet produced an enforceable risk management rule.
What deadline did the EPA miss for legacy asbestos regulation?
Under TSCA, the EPA is required to publish a final risk management rule within 1 year of completing a chemical risk evaluation. The EPA completed its Part 2 risk evaluation for legacy asbestos in late 2024. That statutory deadline passed without EPA publishing a final rule. In February 2026, ADAO filed a 60-day notice of intent to sue the EPA under TSCA Section 20(a)(2) for failing to meet this obligation.
What is the ADAO lawsuit about and what could it accomplish?
ADAO's February 2026 lawsuit notice was filed under TSCA Section 20(a)(2), which allows citizens to sue EPA for failing to perform a non-discretionary duty. If successful, the lawsuit could compel EPA to publish a final rule addressing legacy asbestos in buildings — potentially setting standards for inspection, abatement triggers, and worker protections.
Does the EPA chrysotile asbestos ban protect people from asbestos in existing buildings?
No. The EPA's 2024 Part 1 chrysotile ban is forward-looking. It does not address asbestos already present in buildings, pipes, floor tiles, insulation, and other materials installed decades ago. AHERA governs asbestos in K-12 schools but has no commercial building equivalent.
What legal rights do mesothelioma patients have if they were exposed to legacy asbestos in a building?
People who developed mesothelioma from legacy asbestos exposure in a building may pursue product liability claims against original manufacturers, premises liability claims against building owners who created or failed to disclose hazards, and asbestos trust fund claims against bankrupt manufacturers whose products were installed in the structure.
How does the Fifth Circuit litigation over the chrysotile ban affect EPA's authority to regulate legacy asbestos?
The Fifth Circuit is reviewing challenges to the Part 1 chrysotile ban. A ruling limiting EPA's authority could constrain what a Part 2 legacy asbestos rule may contain. As of March 2026, the chrysotile ban remains fully in effect and enforceable, and the court has not yet issued its ruling.
What Should Building Owners and Workers Do Right Now?
The absence of a federal legacy asbestos rule does not eliminate risk — it only means federal enforcement is limited to specific contexts. Building owners, contractors, and workers have practical steps available today:
- Buildings constructed before 1980: Commission an asbestos survey by a licensed asbestos inspector before any renovation, demolition, or remodeling work. Many states require this as a condition of building permits.
- Workers in renovation or demolition: Demand the employer conduct OSHA-required air monitoring before work begins and provide appropriate PPE if asbestos-containing materials may be present.
- Schools and school districts: Review AHERA management plans to confirm triennial re-inspections are current and that asbestos management plans are updated and communicated to parents and staff.
- Mesothelioma patients and families: Preserve all evidence of where you or your family member lived and worked — building addresses, employer records, and renovation histories are critical to building a compensation case.
For patients who have already been diagnosed with mesothelioma and believe building exposure played a role, asbestos trust fund claims and litigation are available regardless of EPA regulatory status. Our free case assessment is the fastest way to understand your specific options.
References
- EPA Finalizes Ban on Ongoing Uses of Chrysotile Asbestos — EPA.gov
- Asbestos Overview and Regulations — EPA.gov
- Assessing and Managing Chemicals Under TSCA — EPA.gov
- Asbestos Laws and Regulations — EPA.gov
- OSHA Asbestos General Industry Standard 29 CFR 1910.1001 — OSHA.gov
- Asbestos History Timeline — WikiMesothelioma
- Mesothelioma Quick Facts — WikiMesothelioma
- Learn About Asbestos — EPA.gov
- Asbestos Toxicological Profile — ATSDR/CDC
- EPA Chrysotile Asbestos Ban Final Rule — Federal Register
- Chamber Tells Fifth Circuit EPA Asbestos Ban Goes Too Far — Law360
- Trump Administration Pulls Back Plan to Rewrite Asbestos Ban — PBS NewsHour
About the Author
Rod De LlanoFounding Partner at Danziger & De Llano, Princeton graduate with corporate defense background
Related Topics
Related Articles
Asbestos Class Action vs. Individual Mesothelioma Lawsuit: 5 Key Differences That Affect Your Payout
Most mesothelioma patients assume class actions are their only option. Individual lawsuits typically recover far more. Learn the 5 critical differences and why courts banned most asbestos class actions.
Asbestos Litigation Discovery Process: 7 Types of Evidence Your Lawyer Needs
Asbestos litigation discovery requires specific evidence to win mesothelioma lawsuits. Learn the 7 evidence types lawyers gather — from product ID documents to co-worker testimony.
Shotgun Shell Asbestos: $9M Verdict Against DuPont Exposes Hunter Risk
Delaware Superior Court upheld a $9M verdict in 2026 against DuPont and Remington for asbestos in shotgun shell base wads used from the 1960s to 1980s. An estimated 50 million hunters were potentially exposed.
Need Help With Your Case?
If you or a loved one has been diagnosed with mesothelioma, our experienced attorneys can help you understand your options and pursue the compensation you deserve.